Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 93 articles:
HTML format



Single Articles


    June 2021
  1. HESS CN, Fu JW, Gundrum J, Allen LaPointe NM, et al
    Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization.
    J Am Coll Cardiol. 2021;77:2867-2869.
    PubMed    


  2. SANTOS RD, Shapiro MD, Ballantyne CM
    Glycated Hemoglobin to Detect Subclinical Atherosclerosis in People Without Diabetes.
    J Am Coll Cardiol. 2021;77:2792-2795.
    PubMed    


  3. ROSSELLO X, Raposeiras-Roubin S, Oliva B, Sanchez-Cabo F, et al
    Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes.
    J Am Coll Cardiol. 2021;77:2777-2791.
    PubMed     Abstract available


    May 2021
  4. DILLINGER JG, Henry P
    Benefits of Ticagrelor Plus Aspirin According to Diabetes-Related Factors: A Complex Equation.
    J Am Coll Cardiol. 2021;77:2378-2381.
    PubMed    


  5. LEITER LA, Bhatt DL, McGuire DK, Teoh H, et al
    Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
    J Am Coll Cardiol. 2021;77:2366-2377.
    PubMed     Abstract available


  6. FILIPPATOS G, Bakris GL, Pitt B, Agarwal R, et al
    Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04966.
    PubMed     Abstract available


    April 2021
  7. VEDANTHAN R, Kamano JH, Chrysanthopoulou SA, Mugo R, et al
    Group Medical Visit and Microfinance Intervention for Patients With Diabetes or Hypertension in Kenya.
    J Am Coll Cardiol. 2021;77:2007-2018.
    PubMed     Abstract available


  8. CAVALLARI I, Bhatt DL, Steg PG, Leiter LA, et al
    Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.
    J Am Coll Cardiol. 2021;77:1837-1840.
    PubMed    


    March 2021
  9. AGGARWAL R, Chiu N, Loccoh EC, Kazi DS, et al
    Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018.
    J Am Coll Cardiol. 2021;77:1480-1481.
    PubMed    


    February 2021
  10. ZEITLER EP, Piccini JP
    Pre-Diabetes and Stroke in Patients With Atrial Fibrillation: When Risk Begets Risk.
    J Am Coll Cardiol. 2021;77:885-887.
    PubMed    


  11. KEZERLE L, Tsadok MA, Akriv A, Senderey AB, et al
    Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:875-884.
    PubMed     Abstract available


  12. HULOT JS, Livrozet M
    HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes.
    J Am Coll Cardiol. 2021;77:420-422.
    PubMed    


    December 2020
  13. FAXEN J, Jernberg T, Hollenberg J, Gadler F, et al
    Incidence and Predictors of Out-of-Hospital Cardiac Arrest Within 90 Days After Myocardial Infarction.
    J Am Coll Cardiol. 2020;76:2926-2936.
    PubMed     Abstract available


  14. AGGARWAL R, Lu K, Chiu N, Bakris GL, et al
    U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy.
    J Am Coll Cardiol. 2020;76:2907-2910.
    PubMed    


    November 2020
  15. FERRO EG, Michos ED, Bhatt DL, Lincoff AM, et al
    New Decade, New FDA Guidance for Diabetes Drug Development: Lessons Learned and Future Directions.
    J Am Coll Cardiol. 2020;76:2522-2526.
    PubMed    


  16. NAVARESE EP, Brouwer MA, Kubica J
    Long-Term Outcomes Following Coronary Revascularizations in Diabetes Mellitus: The Emerging Role of LDL-C Thresholds.
    J Am Coll Cardiol. 2020;76:2208-2211.
    PubMed    


  17. FARKOUH ME, Godoy LC, Brooks MM, Mancini GBJ, et al
    Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.
    J Am Coll Cardiol. 2020;76:2197-2207.
    PubMed     Abstract available


  18. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
    Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
    PubMed     Abstract available


  19. JANUZZI JL JR, Xu J, Li J, Shaw W, et al
    Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
    J Am Coll Cardiol. 2020;76:2076-2085.
    PubMed     Abstract available


    September 2020
  20. PURI R, Brophy JM, Mack MJ
    Revascularizing Diabetic Multivessel Coronary Artery Disease in the 2020s: Forever Surgically Sweet?
    J Am Coll Cardiol. 2020;76:1165-1167.
    PubMed    


  21. TAM DY, Dharma C, Rocha R, Farkouh ME, et al
    Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.
    J Am Coll Cardiol. 2020;76:1153-1164.
    PubMed     Abstract available


  22. ANGIOLILLO DJ, Baber U, Dangas GD, Mehran R, et al
    Reply: P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent.
    J Am Coll Cardiol. 2020;76:1274-1275.
    PubMed    


  23. CHOUDHARY R, Deora S
    P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent.
    J Am Coll Cardiol. 2020;76:1273-1274.
    PubMed    


    July 2020
  24. DAS SR, Everett BM, Birtcher KK, Brown JM, et al
    2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2020 Jul 28. pii: S0735-1097(20)35391.
    PubMed    


    June 2020
  25. SHAH NS, Carnethon M, Lloyd-Jones DM, Khan SS, et al
    Widening Rural-Urban Cardiometabolic Mortality Gap in the United States, 1999 to 2017.
    J Am Coll Cardiol. 2020;75:3187-3188.
    PubMed    


  26. CAREW AS, Levy AP, Ginsberg HN, Rimm EB, et al
    Reply: Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes.
    J Am Coll Cardiol. 2020;75:2996-2997.
    PubMed    


  27. MORIERI ML, Shah HS, Tang Y, Doria A, et al
    Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes.
    J Am Coll Cardiol. 2020;75:2995-2996.
    PubMed    


    May 2020
  28. CHO L, Davis M, Elgendy I, Epps K, et al
    Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:2602-2618.
    PubMed     Abstract available


  29. SERRUYS PW, Takahashi K, Chichareon P, Onuma Y, et al
    Twilight, the Dawn of a New Era of Aspirin-Free PCI?
    J Am Coll Cardiol. 2020;75:2425-2429.
    PubMed    


    April 2020
  30. WILCOX T, De Block C, Schwartzbard AZ, Newman JD, et al
    Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;75:1956-1974.
    PubMed     Abstract available


    March 2020
  31. ALEXANDER CM
    Is Heart Failure Still the Frequent, Forgotten, and Often Fatal Complication of Diabetes?
    J Am Coll Cardiol. 2020;75:1263-1265.
    PubMed    


  32. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
    Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
    J Am Coll Cardiol. 2020;75:1249-1262.
    PubMed     Abstract available


  33. ANGIOLILLO DJ, Baber U, Sartori S, Briguori C, et al
    Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2020 Mar 19. pii: S0735-1097(20)34530.
    PubMed     Abstract available


  34. DEC GW
    Which Drug Will "Lead" in Reducing Cardiac Events Among Heart Failure Patients With Diabetes?
    J Am Coll Cardiol. 2020;75:1142-1144.
    PubMed    


  35. MARSO SP, Baeres FMM, Bain SC, Goldman B, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.
    J Am Coll Cardiol. 2020;75:1128-1141.
    PubMed     Abstract available


    February 2020
  36. COSTACOU T, Howard BV
    Should the Haptoglobin Genotype Be Considered in Setting Glycemic Goals for Diabetes Patients?
    J Am Coll Cardiol. 2020;75:522-524.
    PubMed    


  37. CAREW AS, Levy AP, Ginsberg HN, Coca S, et al
    Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes.
    J Am Coll Cardiol. 2020;75:512-521.
    PubMed     Abstract available


  38. ZELNIKER TA, Braunwald E
    Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:435-447.
    PubMed     Abstract available


  39. ZELNIKER TA, Braunwald E
    Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:422-434.
    PubMed     Abstract available


    December 2019
  40. GUDBJARTSSON DF, Thorgeirsson G, Sulem P, Helgadottir A, et al
    Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
    J Am Coll Cardiol. 2019;74:2982-2994.
    PubMed     Abstract available


    November 2019
  41. VADUGANATHAN M, Fonarow GC, Greene SJ, DeVore AD, et al
    Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.
    J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38082.
    PubMed    


    October 2019
  42. MUNROE PB, Ramirez J, van Duijvenboden S
    Resting Heart Rate and Type 2 Diabetes: A Complex Relationship in Need of Greater Understanding.
    J Am Coll Cardiol. 2019;74:2175-2177.
    PubMed    


  43. GUO Y, Chung W, Zhu Z, Shan Z, et al
    Genome-Wide Assessment for Resting Heart Rate and Shared Genetics With Cardiometabolic Traits and Type 2 Diabetes.
    J Am Coll Cardiol. 2019;74:2162-2174.
    PubMed     Abstract available


  44. QINTAR M, Humphries KH, Park JE, Arnold SV, et al
    Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.
    J Am Coll Cardiol. 2019;74:2074-2084.
    PubMed     Abstract available


  45. SHAPIRO MD, Maron DJ, Morris PB, Kosiborod M, et al
    Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.
    J Am Coll Cardiol. 2019;74:1926-1942.
    PubMed     Abstract available


    August 2019
  46. WANG A, Green JB, Halperin JL, Piccini JP Sr, et al
    Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:1107-1115.
    PubMed     Abstract available


    July 2019
  47. BHATT DL, Aminian A, Kashyap SR, Kirwan JP, et al
    Cardiovascular Biomarkers After Metabolic Surgery Versus Medical Therapy for Diabetes.
    J Am Coll Cardiol. 2019;74:261-263.
    PubMed    


    April 2019
  48. FARKOUH ME, Godoy LC
    Lifestyle Interventions in Diabetes and Coronary Disease: A Timely Reminder.
    J Am Coll Cardiol. 2019;73:2059-2061.
    PubMed    


  49. MANCINI GBJ, Maron DJ, Hartigan PM, Spertus JA, et al
    Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.
    J Am Coll Cardiol. 2019;73:2049-2058.
    PubMed     Abstract available


  50. PARK SJ, Park DW
    Diabetes in Myocardial Revascularization for Left Main Coronary Artery Disease: Predictor or Decision Maker?
    J Am Coll Cardiol. 2019;73:1629-1632.
    PubMed    


  51. MILOJEVIC M, Serruys PW, Sabik JF 3rd, Kandzari DE, et al
    Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
    J Am Coll Cardiol. 2019;73:1616-1628.
    PubMed     Abstract available


    March 2019
  52. SHARMA A, Coles A, Sekaran NK, Pagidipati NJ, et al
    Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease.
    J Am Coll Cardiol. 2019;73:893-902.
    PubMed     Abstract available


  53. VERMA S, Wanner C, Zwiener I, Ofstad AP, et al
    Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes.
    J Am Coll Cardiol. 2019 Mar 5. pii: S0735-1097(19)33807.
    PubMed    


    February 2019
  54. MCHUGH K, DeVore AD, Wu J, Matsouaka RA, et al
    Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:602-611.
    PubMed     Abstract available


  55. FARKOUH ME, Sidhu MS, Brooks MM, Vlachos H, et al
    Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    J Am Coll Cardiol. 2019;73:400-411.
    PubMed     Abstract available


    December 2018
  56. LOW WANG CC, Blomster JI, Heizer G, Berger JS, et al
    Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
    J Am Coll Cardiol. 2018;72:3274-3284.
    PubMed     Abstract available


  57. LU J, Wang W, Li M, Bi Y, et al
    Associations of Hemoglobin A1c With Cardiovascular Disease and Mortality in Chinese Adults With Diabetes.
    J Am Coll Cardiol. 2018;72:3224-3225.
    PubMed    


  58. KATO K, Cammann VL, Wischnewsky M, Ghadri JR, et al
    Reply: Prevalence of Diabetes Mellitus in Patients With Takotsubo Syndrome, Precipitated by Nonphysical or No Triggers.
    J Am Coll Cardiol. 2018;72.
    PubMed    


  59. MADIAS JE
    Prevalence of Diabetes Mellitus in Patients With Takotsubo Syndrome, Precipitated by Nonphysical or No Triggers.
    J Am Coll Cardiol. 2018;72.
    PubMed    


  60. FEDAK PWM, Bhatt DL, Verma S
    Coronary Bypass Surgery for Diabetes and Multivessel Disease: Forget the SYNTAX.
    J Am Coll Cardiol. 2018;72.
    PubMed    


  61. ESPER RB, Farkouh ME, Ribeiro EE, Hueb W, et al
    SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
    J Am Coll Cardiol. 2018;72.
    PubMed     Abstract available


    November 2018
  62. DAS SR, Everett BM, Birtcher KK, Brown JM, et al
    2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus
    J Am Coll Cardiol. 2018 Nov 24. pii: S0735-1097(18)38498.
    PubMed    


  63. BANGALORE S, Zenati MA
    The "Fragility" of Mortality benefit of Coronary Artery Bypass Graft Surgery in Diabetics.
    J Am Coll Cardiol. 2018 Nov 5. pii: S0735-1097(18)39064.
    PubMed    


  64. FARKOUH ME, Domanski M, Dangas GD, Godoy LC, et al
    Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study).
    J Am Coll Cardiol. 2018 Nov 1. pii: S0735-1097(18)38994.
    PubMed     Abstract available


    October 2018
  65. NEWMAN JD, Vani AK, Aleman JO, Weintraub HS, et al
    The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:1856-1869.
    PubMed     Abstract available


  66. DEEDWANIA P
    Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs.
    J Am Coll Cardiol. 2018;72:1787-1789.
    PubMed    


  67. REZENDE PC, Everett BM, Brooks MM, Vlachos H, et al
    Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease.
    J Am Coll Cardiol. 2018;72:1778-1786.
    PubMed     Abstract available


    September 2018
  68. EVERETT BM, Ridker PM
    Reply: Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting.
    J Am Coll Cardiol. 2018;72:1432-1433.
    PubMed    


  69. PAREEK AK, Messerli FH, Mehta RT, Grover A, et al
    Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting.
    J Am Coll Cardiol. 2018;72:1432.
    PubMed    


  70. KARAYIANNIDES S, Norhammar A, Frobert O, James SK, et al
    Prognosis in Patients With Diabetes Mellitus and STEMI Undergoing Primary PCI.
    J Am Coll Cardiol. 2018;72:1427-1428.
    PubMed    


  71. BAKRIS GL, Polonsky TS
    Presence of Diabetes Does Not Mandate Lower Blood Pressure to Reduce Cardiovascular Events.
    J Am Coll Cardiol. 2018;72:1224-1226.
    PubMed    


  72. BERKOWITZ SA, Sussman JB, Jonas DE, Basu S, et al
    Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus.
    J Am Coll Cardiol. 2018;72:1214-1223.
    PubMed     Abstract available


    August 2018
  73. VILAHUR G
    Red Blood Cells Deserve Attention in Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018;72:781-783.
    PubMed    


  74. ZHOU Z, Mahdi A, Tratsiakovich Y, Zahoran S, et al
    Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I.
    J Am Coll Cardiol. 2018;72:769-780.
    PubMed     Abstract available


    July 2018
  75. ZELNIKER TA, Braunwald E
    Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018 Jul 24. pii: S0735-1097(18)35368.
    PubMed     Abstract available


    June 2018
  76. CONNELLY K, Gandhi S, Horton E
    Lifestyle and CV Risk in Patients With Diabetes: Time to Get "Back to Basics".
    J Am Coll Cardiol. 2018;71:2877-2879.
    PubMed    


  77. LIU G, Li Y, Hu Y, Zong G, et al
    Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2018;71:2867-2876.
    PubMed     Abstract available


    May 2018
  78. VERMA S, Mathew V, Farkouh ME
    Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes: Insights From CANTOS.
    J Am Coll Cardiol. 2018;71:2402-2404.
    PubMed    


    March 2018
  79. GREENE SJ, Vaduganathan M, Khan MS, Bakris GL, et al
    Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018 Mar 10. pii: S0735-1097(18)30326.
    PubMed     Abstract available


  80. EVERETT BM, Donath MY, Pradhan AD, Thuren T, et al
    Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes.
    J Am Coll Cardiol. 2018 Mar 3. pii: S0735-1097(18)33483.
    PubMed     Abstract available


    February 2018
  81. VELAZQUEZ EJ, Petrie MC
    CABG or PCI for Diabetic Patients With Left Ventricular Dysfunction: Closing in on the Truth?
    J Am Coll Cardiol. 2018;71:828-831.
    PubMed    


  82. NAGENDRAN J, Bozso SJ, Norris CM, McAlister FA, et al
    Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2018;71:819-827.
    PubMed     Abstract available


  83. PAREEK M, Schauer PR, Kaplan LM, Leiter LA, et al
    Metabolic Surgery: Weight Loss, Diabetes, and Beyond.
    J Am Coll Cardiol. 2018;71:670-687.
    PubMed     Abstract available


    January 2018
  84. FITCHETT D, Inzucchi SE, Lachin JM, Wanner C, et al
    Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease.
    J Am Coll Cardiol. 2018;71:364-367.
    PubMed    


  85. MARWICK TH, Ritchie R, Shaw JE, Kaye D, et al
    Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    J Am Coll Cardiol. 2018;71:339-351.
    PubMed     Abstract available


    December 2017
  86. BANGALORE S, Bhatt DL
    Do We Need a Trial of DES Versus CABG Surgery in Diabetic Patients With ACS?
    J Am Coll Cardiol. 2017;70:3007-3009.
    PubMed    


  87. RAMANATHAN K, Abel JG, Park JE, Fung A, et al
    Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    J Am Coll Cardiol. 2017;70:2995-3006.
    PubMed     Abstract available


    November 2017
  88. AGIRBASLI M
    Influence of Diabetes on CABG Patency: Targeting Functional Status After CABG in Patients With DM.
    J Am Coll Cardiol. 2017;70:2604.
    PubMed    


    October 2017
  89. HONG KN, Fuster V, Rosenson RS, Rosendorff C, et al
    How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
    J Am Coll Cardiol. 2017;70:2171-2185.
    PubMed     Abstract available


  90. DOMINGUEZ H, Sanchez-Ferrer CF
    The Role of Glycated Proteins on Cardiovascular Diabetic Complications: New Findings.
    J Am Coll Cardiol. 2017;70:2020-2021.
    PubMed    


  91. DAI Y, Shen Y, Li QR, Ding FH, et al
    Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes.
    J Am Coll Cardiol. 2017;70:2006-2019.
    PubMed     Abstract available


  92. GALDERISI M, Esposito R, Trimarco B
    Cardiac Involvement in Diabetes: The Dark Side of the Moon.
    J Am Coll Cardiol. 2017;70:1717-1719.
    PubMed    


  93. ERNANDE L, Audureau E, Jellis CL, Bergerot C, et al
    Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2017;70:1704-1716.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: